Advanced search
Publication Cover
Bioengineered Volume 13, 2022 - Issue 4
Submit an article Journal homepage
2,784
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

c-Met specific CAR-T cells as a targeted therapy for non-small cell lung cancer cell A549

Jingting Mina Department of Basic Medical, Bengbu Medical College, Bengbu, AH, ChinaView further author information
,
Chirong Longa Department of Basic Medical, Bengbu Medical College, Bengbu, AH, ChinaView further author information
,
Lu Zhangb Department of Life Sciences, Bengbu Medical College, Bengbu, AH, ChinaView further author information
,
Jiakang Duanc Department of Hepatological Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu, AH, ChinaView further author information
,
Honglian Fand Department of Pharmacy, Bengbu Medical College, Bengbu, AH, ChinaView further author information
,
Fei Chue Department of Pharmacy, The First Affiliated Hospital of Bengbu Medical College, Bengbu, AH, ChinaView further author information
&
Zhenghong Lib Department of Life Sciences, Bengbu Medical College, Bengbu, AH, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 9232-9248 | Received 27 Dec 2021, Accepted 21 Mar 2022, Published online: 04 Apr 2022

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

John Maher. (2023) Chimeric Antigen Receptor (CAR) T-Cell Therapy for Patients with Lung Cancer: Current Perspectives. OncoTargets and Therapy 16, pages 515-532.
Read now
Haiyan Ma, Wenwen Wei, Dandan Liang, Xing Xu, Dong Yang, Qiong Wang, Yun Wang, Quan Wei, Bin Sun & Xudong Zhao. (2023) HGF-Based CAR-T Cells Target Hepatocellular Carcinoma Cells That Express High Levels of c-Met. Immunological Investigations 52:6, pages 735-748.
Read now

Articles from other publishers (5)

Chunsen Wang, Xiang Yuan & Jianxin Xue. (2023) Targeted therapy for rare lung cancers: Status, challenges, and prospects. Molecular Therapy 31:7, pages 1960-1978.
Crossref
Payal D. Shah, Alexander C. Huang, Xiaowei Xu, Robert Orlowski, Ravi K. Amaravadi, Lynn M. Schuchter, Paul Zhang, Julia Tchou, Tina Matlawski, Amanda Cervini, Joanne Shea, Joan Gilmore, Lester Lledo, Karen Dengel, Amy Marshall, E. John Wherry, Gerald P. Linette, Andrea Brennan, Vanessa Gonzalez, Irina Kulikovskaya, Simon F. Lacey, Gabriela Plesa, Carl H. June, Robert H. Vonderheide & Tara C. Mitchell. (2023) Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma. Cancer Research Communications 3:5, pages 821-829.
Crossref
Cristina Chiriaco, Chiara Donini, Marco Cortese, Stefano Ughetto, Chiara Modica, Ilaria Martinelli, Alessia Proment, Letizia Vitali, Lara Fontani, Monica Casucci, Paolo Maria Comoglio, Silvia Giordano, Dario Sangiolo, Valeria Leuci & Elisa Vigna. (2022) Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Chunrun Qu, Hao Zhang, Hui Cao, Lanhua Tang, Haoyang Mo, Fangkun Liu, Liyang Zhang, Zhenjie Yi, Lifu Long, Luzhe Yan, Zeyu Wang, Nan Zhang, Peng Luo, Jian Zhang, Zaoqu Liu, Weijie Ye, Zhixiong Liu & Quan Cheng. (2022) Tumor buster - where will the CAR-T cell therapy ‘missile’ go?. Molecular Cancer 21:1.
Crossref
Ruizhu Sun, Zhansheng Hou, Yankui Zhang & Bo Jiang. (2022) Drug resistance mechanisms and progress in the treatment of EGFR‑mutated lung adenocarcinoma (Review). Oncology Letters 24:5.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.